Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Review article: the diagnosis of non‐alcoholic fatty liver disease – availability and accuracy of non‐invasive methods

Open access
Festi, D., Schiumerini, R., Marzi, L., Di Biase, A. R., Mandolesi, D., Montrone, L., Scaioli, E., Bonato, G., Marchesini‐Reggiani, G., Colecchia, A.·2013·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Non‐alcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of clinical conditions, actually representing an emerging disease of great clinical interest. Currently, its diagnosis requires liver biopsy, an invasive procedure not free from potential complications. However, several non‐invasive diagnostic strategies have been proposed as potential diagnostic alternatives, each with different sensitivities and accuracies. Aim: To review non‐invasive diagnostic parameters and tools for NAFLD diagnosis and to formulate a diagnostic and prognostic algorithm for a better classification of patients. Methods: A literature search was carried out on MEDLINE, EMBASE, Web of Science and Scopus for articles and abstracts in English. The search terms used included ‘NAFLD’, ‘non invasive method and NAFLD’, ‘transient elastography’ and ‘liver fibrosis’. The articles cited were selected based on their relevancy to the objective of the review. Results: Ultrasonography still represents the first‐line diagnostic tool for simple liver steatosis; its sensitivity could be enhanced by the complex biochemical score SteatoTest. Serum cytokeratin‐18 is a promising and accurate non‐invasive parameter (AUROC s: 0.83; 0.91) for the diagnosis of non‐alcoholic steatohepatitis (NASH). The staging of liver fibrosis still represents the most important prognostic problem: the most accurate estimating methods are FibroMeter, FIB‐4, NAFLD fibrosis score (AUROC s: 0.94; 0.86; 0.82) and transient elastography (AUROC: 0.84–1.00). Conclusions: Different non‐invasive parameters are available for the accurate diagnosis and prognostic stratification of non‐alcoholic fatty liver disease which, if employed in a sequential algorithm, may lead to a reduced use of invasive methods, i.e. liver biopsy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.12186

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 185

Metadata

Authors
Festi, D., Schiumerini, R., Marzi, L., Di Biase, A. R., Mandolesi, D., Montrone, L., Scaioli, E., Bonato, G., Marchesini‐Reggiani, G., & Colecchia, A.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2012-12-20
Volume
37
Issue
4
Pages
392-400
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1972893099
Cited by
185
References
5
FWCI
14.43
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review article: the diagnosis of non‐alcoholic fatty liver disease – availability and accuracy of non‐invasive methods. https://app.cochat.ai/papers/10.1111/apt.12186
The paper
Festi, D., Schiumerini, R., Marzi, L., Di Biase, A. R., Mandolesi, D., Montrone, L., Scaioli, E., Bonato, G., Marchesini‐Reggiani, G., & Colecchia, A. (2013). Review article: the diagnosis of non‐alcoholic fatty liver disease – availability and accuracy of non‐invasive methods. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.12186

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.